No Cure Left. Now Cancer-Free.
His kidney cancer had spread to his brain, lungs, and liver — and doctors had no approved treatment left to offer. One experimental infusion later, this German teenager is cancer-free and back racing his mountain bike.
✓ Verified · cross-checked against 2 independent sources
Ten years ago, a seven-year-old boy in Germany got the diagnosis every parent dreads: a tumor on his kidney. He fought it back, treatment after treatment — until, at seventeen, the cancer did the one thing his doctors feared most. It spread. To his lungs. His liver. His brain. And this time, there was no approved treatment left to try.
His medical team, at the Hopp Children's Cancer Center in Heidelberg, had one long-shot idea left. For a decade, the rule in cancer treatment had been simple: engineered immune-cell therapies work on cancers of the blood, not on big, solid tumors like his. The tumor's own defenses were too good at keeping immune cells out.
But doctors led by Dr. Christian Seitz noticed something. His cancer cells were coated in a marker called PRAME — the same target researchers had been chasing in adult melanoma patients, with real success. So his team, working with a biotech partner in Tübingen, took his own T-cells, reprogrammed them to hunt that one marker, and sent them back into his body. Once.
Nine days later, a biopsy showed the T-cells swarming the tumor, killing cancer cells on contact. Three months in, doctors went looking for any living tumor cells left in his body. They found none. "I was looking at the images, and I was like, this is not possible," Dr. Seitz said.
Today — almost a year after that single infusion — scans and blood tests still show no sign of the disease.
Here's the part that gets me. This is a kid who spent a decade in and out of hospitals. And when he finally got his body back, he didn't ask for rest. He asked for his mountain bike. He's back on the trails now, training every week, racing competitively — including a run down the Bike Festival course in Riva del Garda, Italy. He's been riding hard enough, in fact, that his own doctor recently found himself checking in before one race with a simple request: please don't crash into a tree.
Worth saying plainly: this is one compassionate-use case, not yet an approved therapy anyone can walk in and request. But it's already changing what doctors thought was possible. A clinical trial is now being planned for 2027, funded in part by the Dietmar Hopp Foundation, to test this same approach in up to eighteen more children and teenagers whose tumors carry that same PRAME marker. One "impossible" case just became the blueprint for the next one.
We talk a lot on this channel about second chances. This is what one actually looks like — not just survival, but a teenager choosing, entirely on his own terms, to go fly down a mountain on two wheels.
Enjoy good news? Get your daily dose of sunshine free →
This post may contain affiliate links; we may earn a small commission at no cost to you. AI disclosure: our videos are produced with AI tools (ElevenLabs voice, Pictory) with human research, fact-checking, and editorial review on every story.
